JPWO2022050300A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022050300A5
JPWO2022050300A5 JP2022546941A JP2022546941A JPWO2022050300A5 JP WO2022050300 A5 JPWO2022050300 A5 JP WO2022050300A5 JP 2022546941 A JP2022546941 A JP 2022546941A JP 2022546941 A JP2022546941 A JP 2022546941A JP WO2022050300 A5 JPWO2022050300 A5 JP WO2022050300A5
Authority
JP
Japan
Prior art keywords
endo
molecule
amino acid
oxy
oxo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022546941A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2022050300A1 (https=
JP7798773B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2021/032083 external-priority patent/WO2022050300A1/ja
Publication of JPWO2022050300A1 publication Critical patent/JPWO2022050300A1/ja
Publication of JPWO2022050300A5 publication Critical patent/JPWO2022050300A5/ja
Application granted granted Critical
Publication of JP7798773B2 publication Critical patent/JP7798773B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022546941A 2020-09-02 2021-09-01 新規エンド-β-N-アセチルグルコサミニダーゼ Active JP7798773B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020147745 2020-09-02
JP2020147745 2020-09-02
PCT/JP2021/032083 WO2022050300A1 (ja) 2020-09-02 2021-09-01 新規エンド-β-N-アセチルグルコサミニダーゼ

Publications (3)

Publication Number Publication Date
JPWO2022050300A1 JPWO2022050300A1 (https=) 2022-03-10
JPWO2022050300A5 true JPWO2022050300A5 (https=) 2024-09-02
JP7798773B2 JP7798773B2 (ja) 2026-01-14

Family

ID=80492267

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022546941A Active JP7798773B2 (ja) 2020-09-02 2021-09-01 新規エンド-β-N-アセチルグルコサミニダーゼ

Country Status (9)

Country Link
US (1) US20240336907A1 (https=)
EP (1) EP4209506A4 (https=)
JP (1) JP7798773B2 (https=)
KR (1) KR20230061360A (https=)
CN (1) CN116113641A (https=)
AU (1) AU2021338014A1 (https=)
CA (1) CA3191395A1 (https=)
TW (1) TW202227479A (https=)
WO (1) WO2022050300A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL312728A (en) 2021-11-30 2024-07-01 Daiichi Sankyo Co Ltd Protease-cleavable masked antibodies
TW202342106A (zh) 2022-02-09 2023-11-01 日商第一三共股份有限公司 環境應答性遮蔽抗體及其利用
CN118804983A (zh) 2022-03-02 2024-10-18 第一三共株式会社 含Fc分子的制造方法
KR20250054799A (ko) 2022-08-29 2025-04-23 다이이찌 산쿄 가부시키가이샤 변이 Fc 영역을 포함하는 항체 약물 콘쥬게이트
KR20250064682A (ko) 2022-09-09 2025-05-09 다이이찌 산쿄 가부시키가이샤 신규 올리고당, 그 올리고당의 제조 중간체, 및 그것들의 제조 방법
JP2024054523A (ja) * 2022-10-05 2024-04-17 日本マイクロバイオファーマ株式会社 抗体薬物複合体の製造方法及びそれに用いる酵素
KR20250138255A (ko) 2023-01-27 2025-09-19 다이이찌 산쿄 가부시키가이샤 항 lrrc15 항체
WO2025148976A1 (zh) * 2024-01-10 2025-07-17 上海齐鲁制药研究中心有限公司 新型beta-N-乙酰氨基葡萄糖苷内切酶及其用途
CN118308329B (zh) * 2024-06-11 2024-08-06 中国海洋大学 β-N-乙酰氨基己糖苷酶D297K及其应用
CN118325869B (zh) * 2024-06-12 2024-10-22 上海盛迪医药有限公司 一种内-β-N-乙酰葡糖苷酶变体

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2795349C (en) 2010-04-15 2016-11-29 Seattle Genetics, Inc. Targeted pyrrolobenzodiazepine conjugates
IN2014DN06806A (https=) 2012-02-10 2015-05-22 Univ Maryland
US20130309223A1 (en) 2012-05-18 2013-11-21 Seattle Genetics, Inc. CD33 Antibodies And Use Of Same To Treat Cancer
ES2773710T3 (es) 2012-10-11 2020-07-14 Daiichi Sankyo Co Ltd Enlazadores para conjugados de anticuerpo - fármaco
US9695212B2 (en) 2012-12-13 2017-07-04 Aduro Biotech, Inc. Compositions comprising cyclic purine dinucleotides having defined stereochemistries and methods for their preparation and use
EP2934598B1 (en) 2012-12-19 2018-04-18 Board Of Regents, The University Of Texas System Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway
ES2731681T3 (es) 2013-02-22 2019-11-18 Abbvie Stemcentrx Llc Conjugados de anticuerpo anti-DLL3 y PBD y usos de los mismos
US9840533B2 (en) 2013-04-29 2017-12-12 Memorial Sloan Kettering Cancer Center Compositions and methods for altering second messenger signaling
PE20160080A1 (es) 2013-05-18 2016-02-21 Aduro Biotech Inc Composiciones y metodos para activar la senalizacion que depende del estimulador del gen de interferon
WO2014189806A1 (en) 2013-05-18 2014-11-27 Aduro Biotech, Inc. Compositions and methods for inhibiting "stimulator of interferon gene" dependent signalling
KR20160047567A (ko) 2013-08-28 2016-05-02 스템센트알엑스 인코포레이티드 조작된 항-dll3 접합체 및 사용 방법
WO2015052534A1 (en) 2013-10-11 2015-04-16 Spirogen Sàrl Pyrrolobenzodiazepine-antibody conjugates
GB201317982D0 (en) 2013-10-11 2013-11-27 Spirogen Sarl Pyrrolobenzodiazepines and conjugates thereof
GB201317981D0 (en) 2013-10-11 2013-11-27 Spirogen Sarl Pyrrolobenzodiazepines and conjugates thereof
WO2015074145A1 (en) 2013-11-22 2015-05-28 Brock University Use of fluorinated cyclic dinucleotides as oral vaccine adjuvants
KR102337414B1 (ko) 2013-12-16 2021-12-10 제넨테크, 인크. 펩타이드 모방체 화합물 및 이의 항체-약물 컨쥬게이트
CR20160564A (es) 2014-06-04 2017-01-20 Glaxosmithkline Ip Dev Ltd Dinucleótidos cíclicos como moduladores de sting
DE102014214408A1 (de) 2014-07-23 2016-01-28 Wacker Chemie Ag Härtbare Organopolysiloxanzusammensetzungen
BR102014018190B1 (pt) 2014-07-24 2020-10-20 Fabio Eduardo Sabonge Cunha suporte para placa de sinalização vertical
WO2016036804A1 (en) 2014-09-03 2016-03-10 Immunogen, Inc. Cytotoxic benzodiazepine derivatives
EP4530348A3 (en) 2014-12-15 2025-08-06 Basf Se Detergent composition comprising subtilase variants
EA035817B1 (ru) 2015-03-10 2020-08-14 Адуро Байотек, Инк. Композиции и способы для активации сигналинга, зависимого от "гена стимулятора интерферона"
SMT202000614T1 (it) 2015-06-29 2021-01-05 Immunogen Inc Coniugati di anticorpi ingegnerizzati con cisteina
JP6744738B2 (ja) * 2015-06-29 2020-08-19 公益財団法人野口研究所 グライコシンターゼ
SG10202005460RA (en) 2015-06-30 2020-07-29 Seattle Genetics Inc Anti-ntb-a antibodies and related compositions and methods
CN108026518B (zh) * 2015-07-16 2022-09-06 第一三共株式会社 新型endos突变型酶
GB201513607D0 (en) 2015-07-31 2015-09-16 Feingold Jay M Pyrrolobenzodiazepine-antibody conjugates
KR102222186B1 (ko) 2015-08-13 2021-03-03 머크 샤프 앤드 돔 코포레이션 Sting 효능제로서 시클릭 디-뉴클레오티드 화합물
JP2018534295A (ja) 2015-10-28 2018-11-22 アドゥロ バイオテック,インク. 「インターフェロン遺伝子刺激因子」依存性シグナル伝達を活性化するための組成物および方法
CN107849084B (zh) 2015-12-03 2021-09-14 葛兰素史密斯克莱知识产权发展有限公司 作为sting调节剂的环状嘌呤二核苷酸
DE212016000029U1 (de) 2015-12-07 2017-07-30 Opi Vi - Ip Holdco Llc Zusammensetzungen von Antikörperkonstrukt-Agonist-Konjugaten
KR102789862B1 (ko) 2016-01-11 2025-04-03 인네이트 튜머 이뮤니티, 인코포레이티드 Sting 활성과 연관된 상태 예컨대 암의 치료를 위한 시클릭 디뉴클레오티드
WO2017124084A1 (en) 2016-01-15 2017-07-20 University Of Maryland, College Park Endo-s2 mutants as glycosynthases, method of making and use for glycoengineering of glycoproteins
NZ746112A (en) 2016-03-18 2023-01-27 Immune Sensor Llc Cyclic di-nucleotide compounds and methods of use
JP2019510802A (ja) 2016-04-07 2019-04-18 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited タンパク質調節物質として有用な複素環アミド
PT3440076T (pt) 2016-04-07 2022-07-29 Glaxosmithkline Ip Dev Ltd Amidas heterocíclicas úteis como modeladores de proteína
WO2018003983A1 (ja) 2016-07-01 2018-01-04 第一三共株式会社 hANP-Fc含有分子コンジュゲート
EP3507367A4 (en) 2016-07-05 2020-03-25 Aduro BioTech, Inc. CYCLIC DINUCLEOTID COMPOUNDS WITH INCLUDED NUCLEIC ACIDS AND USES THEREOF
IL264049B2 (en) 2016-07-06 2023-11-01 Sperovie Biosciences Inc Compounds, preparations and methods for treating the disease
WO2018039373A1 (en) 2016-08-24 2018-03-01 Cho Pharma Inc Endoglycosidase mutants for glycoprotein remodeling and methods of using it
US20190345191A1 (en) 2016-08-31 2019-11-14 Innate Tumor Immunity, Inc. Cyclic dinucleotide analogs for treating conditions associated with sting (stimulator of interferon genes) activity
US10537590B2 (en) 2016-09-30 2020-01-21 Boehringer Ingelheim International Gmbh Cyclic dinucleotide compounds
PT3523287T (pt) 2016-10-04 2021-10-06 Merck Sharp & Dohme Compostos de benzo[b]tiofeno como agonistas de sting
US11001605B2 (en) 2016-10-07 2021-05-11 Biolog Life Science Institute Gmbh & Co. Kg Cyclic dinucleotides containing benzimidazole, method for the production of same, and use of same to activate stimulator of interferon genes (sting)-dependent signaling pathways
US11242593B2 (en) 2016-11-30 2022-02-08 Jfe Steel Corporation Steel for nitrocarburizing, and component
PE20210255A1 (es) 2016-12-01 2021-02-10 Takeda Pharmaceuticals Co Dinucleotido ciclico como agonistas de sting (estimulador de genes de interferon)
NZ762505A (en) * 2017-09-29 2026-03-27 Daiichi Sankyo Co Ltd Antibody-pyrrolobenzodiazepine derivative conjugate
TW202504930A (zh) * 2018-06-27 2025-02-01 台灣浩鼎生技股份有限公司 用於糖蛋白工程的糖苷合成酶變體及其使用方法
JP7510249B2 (ja) 2018-07-28 2024-07-03 公益財団法人野口研究所 複合型糖鎖を遊離する方法
EP3848054B1 (en) * 2018-09-06 2025-01-29 Daiichi Sankyo Company, Limited Antibody-drug conjugates of cyclic dinucleotide derivatives
JP6732150B1 (ja) 2019-03-06 2020-07-29 東京インキ株式会社 熱ラミネート用スチレンフィルム用グラビア印刷インキ組成物

Similar Documents

Publication Publication Date Title
JPWO2022050300A5 (https=)
CN113038964B (zh) 超长效胰岛素-fc融合蛋白及使用方法
Loosfelt et al. Two-subunit structure of the human thyrotropin receptor.
UA130083C2 (uk) Конструкція, що має sirp-альфа домен або її варіант
CN113939528B (zh) 增殖免疫细胞的il-2突变体蛋白
EP3642338B1 (en) Fusion protein with half-life extending polypeptide
Chaturvedi et al. Peptide analogs with different affinities for MHC alter the cytokine profile of T helper cells
TW202214677A (zh) Il-2突變體及其應用
CN115666631A (zh) Cd40结合蛋白
WO2024008110A1 (zh) 抗ccr8抗体及其应用
CN107810195B (zh) 重组丛生蛋白及其在疾病治疗和预防中的应用
CN118206647B (zh) 检测羧基化骨钙素的抗体及试剂盒
CN114269937B (zh) 重组唾液酸酶及其使用方法
TW201837053A (zh) 具有消耗活性的人源化cxcr3抗體及其使用方法
WO1992013887A1 (en) New cell adhesion peptides
Pardridge Physiologic-based strategies for protein drug delivery to the brain
MacAdam et al. Anti-mucus polyclonal antibody production, purification and linkage to the surface of albumin microspheres
CN114173813A (zh) 抗b7-h3抗体及其使用方法
CN116082526B (zh) Iv型胶原蛋白重组抗原及应用
CN118909106B (zh) 非羧基化骨钙素检测方法及检测试剂盒
CN114099424B (zh) 一种重组免疫细胞因子的制剂
WO2020202097A1 (en) Anti-hla-c antibodies and uses thereof
HK40057771B (zh) 增殖免疫细胞的il-2突变体蛋白
CN113004407B (zh) Lag3抗体及其应用
CN120769865A (zh) 结合分子